London School of Hygiene and Tropical Medicine, London, UK.
Epidemiol Infect. 2013 Jun;141(6):1223-31. doi: 10.1017/S095026881200163X. Epub 2012 Jul 30.
Completion of treatment is key to tuberculosis control. Using national surveillance data we assessed factors associated with tuberculosis patients being lost to follow-up before completing treatment ('lost'). Patients reported in England, Wales and Northern Ireland between 2001 and 2007 who were lost 12 months after beginning treatment were compared to those who completed, or were still on treatment, using univariable and multivariable logistic regression. Of 41 120 patients, men [adjusted odds ratio (aOR) 1·29; 95% confidence interval (CI) 1·23-1·35], 15- to 44-year-olds (P<0·001), and patients with pulmonary sputum smear-positive disease (aOR 1·25, 95% CI 1·12-1·45) were at higher risk of being lost. Those recently arrived in the UK were also at increased risk, particularly those of the White ethnic group (aOR 6·39, 95% CI 4·46-9·14). Finally, lost patients had a higher risk of drug resistance (aOR 1·41, 95% CI 1·17-1·69). Patients at risk of being lost require enhanced case management and novel case retention methods are needed to prevent this group contributing towards onward transmission.
完成治疗是结核病控制的关键。我们利用国家监测数据评估了与结核病患者在完成治疗前(“失访”)失访相关的因素。将 2001 年至 2007 年期间在英格兰、威尔士和北爱尔兰报告的治疗开始后 12 个月失访的患者与完成治疗或仍在治疗的患者进行比较,采用单变量和多变量逻辑回归。在 41120 名患者中,男性(调整后的优势比[aOR]1.29;95%置信区间[CI]1.23-1.35)、15-44 岁患者(P<0.001)和肺部痰涂片阳性疾病患者(aOR 1.25,95%CI 1.12-1.45)更有可能失访。最近抵达英国的患者也面临更高的风险,尤其是白人种族群体(aOR 6.39,95%CI 4.46-9.14)。最后,失访患者有更高的耐药风险(aOR 1.41,95%CI 1.17-1.69)。有失访风险的患者需要加强病例管理,需要采用新的病例保留方法来防止这一群体导致疾病继续传播。